Recurrent disease after pediatric renal transplantation

Area of Science:

• Nephrology
• Transplantation Immunology
• Genitourinary Medicine

Background:

• Recurrent diseases are a significant cause of kidney allograft failure, particularly in pediatric recipients.
• Understanding the pathophysiology of these conditions is crucial for improving patient outcomes.
• Recent scientific and therapeutic advancements offer new hope for managing post-transplant complications.

Purpose of the Study:

• To review the current literature on recurrent diseases after kidney transplantation.
• To discuss the diagnosis and management strategies for these conditions.
• To highlight emerging insights into the pathophysiology and treatment of specific recurrent diseases.

Main Methods:

• Comprehensive literature review of relevant studies.
• Analysis of diagnostic criteria and management protocols.
• Synthesis of recent findings on disease mechanisms and therapeutic interventions.

Main Results:

• Recurrent diseases account for 7-8% of kidney allograft loss.
• Diagnosis and management of recurrent diseases are complex and evolving.
• New therapeutic approaches are showing promise in altering the course of several conditions.

Conclusions:

• Advances in understanding pathophysiology and treatment are improving outcomes for post-transplant primary hyperoxaluria, focal segmental glomerulosclerosis, immune complex glomerulonephritis, C3 glomerulopathy, lupus nephritis, atypical hemolytic uremic syndrome, and IgA nephropathy.
• Continued research is vital for further optimizing the care of kidney transplant recipients experiencing recurrent disease.